Biovitrum AB (publ) announces terms of the rights issue
Read the whole press release at:http://www.biovitrum.com/templates/InformationPage.aspx?id=818 For further information, please contact: Biovitrum AB (publ)Martin Nicklasson, CEOPhone: +46 8 697 20 00 Göran Arvidson, CFOPhone: +46 70 633 30 42 Erik Kinnman, VP Investor RelationsPhone: +46 73 422 15 40erik.kinnman@biovitrum.com About BiovitrumBiovitrum is an international pharmaceutical company that marketsspecialist pharmaceuticals in several regions. Using its expertiseand experience Biovitrum takes scientific innovation to patients withsignificant unmet medical need.